The loss of YBX1 was suggested to overcome tyrosine kinase inhibitor resistance, although this study indicates that YBX1 functions to mediate DNA damage repair and thus the loss of YBX1 via USP47 inhibition leads CML cells to cell cycle arrest and apoptosis. Here, YBX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.